Multi-target QSPR assemble of a Complex Network for the distribution of chemicals to biphasic systems and biological tissues

Chemometrics and Intelligent Laboratory Systems

Volumn 94, Issue 2, 2008, Pages 160-165

  González Díaz, Humberto ^a,b   Cabrera Pérez, Miguel A ^c,d,e   Agüero Chapín, Guillermín ^b,c   Cruz Monteagudo, Maykel ^b,c   Castañeda Cancio, Nilo ^c   del Río, Miguel A ^f   Uriarte, Eugenio ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Institute of Industrial Pharmacy   (Spain)

^c CEQA   (Cuba)

^d UNIVERSITY OF VALENCIA   (Spain)

^e USC ^*  (Canada)

^f Department of Pharmacology   (Spain)

Author keywords

Antibacterial compounds; Antimicrobial drugs; Complex Networks; Markov chains; Partition coefficient; QSPR; Spectral moments; Tissue distribution; Topological indices

Indexed keywords

ANTIINFECTIVE AGENT; CHEMICAL COMPOUND;

ALGORITHM; ANIMAL TISSUE; ARTICLE; ATOM; BRAIN; CHEMOMETRICS; DRUG DISTRIBUTION; HEART; NONHUMAN; PARAMETER; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE STRUCTURE PROPERTY RELATION; RAT; SKIN; SPECTROSCOPY; TISSUE DISTRIBUTION;

EID: 53349164135     PISSN: 01697439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemolab.2008.07.006     Document Type: Article

References (38)

1. Klopman G., and Zhu H. Recent methodologies for the estimation of n-octanol/water partition coefficients and their use in the prediction of membrane transport properties of drugs. Mini Rev. Med. Chem. 5 (2005) 127-133
2. Nguyen T.H., Goss K.U., and Ball W.P. Polyparameter linear free energy relationships for estimating the equilibrium partition of organic compounds between water and the natural organic matter in soils and sediments. Environ. Sci. Technol. 39 (2005) 913-924
3. Hendriks A.J., Traas T.P., and Huijbregts M.A. Critical body residues linked to octanol-water partitioning, organism composition, and LC50 QSARs: meta-analysis and model. Environ. Sci. Technol. 39 (2005) 3226-3236
4. Yap C.W., and Chen Y.Z. Quantitative structure-pharmacokinetic relationships for drug distribution properties by using general regression neural network. J. Pharm. Sci. 94 (2005) 153-168
5. Atkinson H.C., and Begg E.J. Prediction of drug distribution into human milk from physicochemical characteristics. Clin. Pharmacokinet. 18 (1990) 151-167
6. Schuurmann G., Ebert R.U., and Kuhne R. Prediction of the sorption of organic compounds into soil organic matter from molecular structure. Environ. Sci. Technol. 40 (2006) 7005-7011
7. Todeschini R., and Consonni V. Handbook of Molecular Descriptors (2002), Wiley-VCH
8. Estrada E., and González-Díaz H. What are the limits of applicability for graph theoretic descriptors in QSPR/QSAR? modeling dipole moments of aromatic compounds with TOPS-MODE descriptors. J. Chem. Inf. Comput. Sci. 43 (2003) 75-84
9. Estrada E., and Rodriguez-Velazquez J.A. Subgraph centrality in complex networks. Phys. Rev. E 71 (2005) 056103
10. Ramos de Armas R., González-Díaz H., Molina R., and Uriarte E. Markovian Backbone Negentropies: molecular descriptors for protein research. I. Predicting protein stability in Arc repressor mutants. Proteins 56 (2004) 715-723
11. Perez Gonzalez M., and Morales Helguera A. TOPS-MODE versus DRAGON descriptors to predict permeability coefficients through low-density polyethylene. J. Comput. Aided Mol. Des. 17 (2003) 665-672
12. Ravasz E., and Barabasi A.L. Hierarchical organization in complex networks. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 67 (2003) 026112
13. Fernandez-Serra M.V., and Artacho E. Electrons and hydrogen-bond connectivity in liquid water. Phys. Rev. Lett. 96 (2006) 016404
14. Rogers B.P., Morgan V.L., Newton A.T., and Gore J.C. Assessing functional connectivity in the human brain by fMRI. Magn. Reson. Imaging 25 10 (2007) 1347-1357
15. Yook S.H., Jeong H., and Barabasi A.L. Modeling the Internet's large-scale topology. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13382-13386
16. Faccioli P., Provero P., Herrmann C., Stanca A.M., Morcia C., and Terzi V. From single genes to co-expression networks: extracting knowledge from barley functional genomics. Plant Mol. Biol. 58 (2005) 739-750
17. Ravasz E., Somera A.L., Mongru D.A., Oltvai Z.N., and Barabasi A.L. Hierarchical organization of modularity in metabolic networks. Science 297 (2002) 1551-1555
18. De P., Singh A.E., Wong T., Yacoub W., and Jolly A.M. Sexual network analysis of a gonorrhoea outbreak. Sex. Transm. Infect. 80 (2004) 280-285
19. Menke R. Linked: The New Science of Networks (review). Perspect. Biol. Med. 47 (2004) 300-303
20. Gonzalez-Diaz H., Aguero G., Cabrera M.A., Molina R., Santana L., Uriarte E., Delogu G., and Castanedo N. Unified Markov thermodynamics based on stochastic forms to classify drugs considering molecular structure, partition system, and biological species: distribution of the antimicrobial G1 on rat tissues. Bioorg. Med. Chem. Lett. 15 (2005) 551-557
21. Gonzalez-Diaz H., Prado-Prado F.J., Santana L., and Uriarte E. Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species. Bioorg. Med. Chem. 14 (2006) 5973-5980
22. González-Díaz H., and Prado-Prado F. Unified QSAR and network-based computational chemistry approach to antimicrobials, Part 1: multispecies activity models for antifungals. J. Comput. Chem. 29 (2008) 656-657
23. Prado-Prado F., González-Díaz H., Santana L., and Uriarte E. Unified QSAR approach to antimicrobials. Part 2: Predicting activity against more than 90 different species in order to halt antibacterial resistance. Bioorg. Med. Chem. 15 (2007) 897-902
24. González-Díaz H., Prado-Prado F.J., Santana L., and Uriarte E. Unify QSAR approach to antimicrobials. Part 1: Predicting antifungal activity against different species. Bioorg. Med. Chem. 14 (2006) 5973-5980
25. Prado-Prado F.J., González-Díaz H., Martinez de la Vega O., Ubeira F.M., and Chou K.C. Unified QSAR approach to antimicrobials. Part 3: First multi-tasking QSAR model for Input-Coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg. Med. Chem. 16 (2008) 5871-5880
26. H. González-Díaz, R. Molina-Ruiz, and I. Hernandez, MARCH-INSIDE version 3.0 (MARkov CHains INvariants for SImulation & DEsign), 2007, MARCH-INSIDE v3.0 (MARkov CHains INvariants for SImulation & DEsign); Windows supported version under request to the main author contact email: gonzalezdiazh@yahoo.es.
27. V. Batagelj, and A. Mrvar, Pajek 1.15. (2006).
28. D. Koschützki, CentiBiN Version 1.4.2, 2006, pp. CentiBiN Version 1.4.2, Centralities in Biological Networks © 2004-2006 Dirk Koschützki Research Group Network Analysis, IPK Gatersleben, Germany.
29. Statsoft_Inc. STATISTICA (2001), Statsoft Inc.
30. Francis L.S., and James M.J. Preclinical Drug Disposition: A Laboratory Handbook (1991), Marcel Dekker Inc, New York 17-49
31. Smith P.L. Methods for evaluating intestinal permeability and metabolism in vitro. In: Borchardt R.T. (Ed). Models for Assessing Drug Absorption and Metabolism (1996), Plenum Press, New York 13-34
32. Casanola-Martin G.M., Marrero-Ponce Y., Khan M.T., Ather A., Khan K.M., Torrens F., and Rotondo R. Dragon method for finding novel tyrosinase inhibitors: biosilico identification and experimental in vitro assays. Eur. J. Med. Chem. 42 (2007) 1370-1381
33. Casanola-Martin G.M., Marrero-Ponce Y., Khan M.T., Ather A., Sultan S., Torrens F., and Rotondo R. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices. Bioorg. Med. Chem. 15 (2007) 1483-1503
34. Castillo-Garit J.A., Marrero-Ponce Y., Torrens F., and Rotondo R. Atom-based stochastic and non-stochastic 3D-chiral bilinear indices and their applications to central chirality codification. J. Mol. Graph. Model. 26 (2007) 32-47
35. Marrero-Ponce Y., Khan M.T., Casanola Martin G.M., Ather A., Sultankhodzhaev M.N., Torrens F., and Rotondo R. Prediction of Tyrosinase Inhibition Activity Using Atom-Based Bilinear Indices. ChemMedChem vol. 2 (2007) 449-478
36. Joly V., and Yeni P. Vectorization of drugs. A winsome concept with delicate practical applications. Rev. Prat. 43 (1993) 2100-2103
37. Temsamani J., Bonnafous C., Rousselle C., Fraisse Y., Clair P., Granier L.A., Rees A.R., Kaczorek M., and Scherrmann J.M. Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy. J. Pharmacol. Exp. Ther. 313 (2005) 712-719
38. Blondeau J.M., Castañedo N., Gonzalez O., Medina R., and Silveira E. Antimicrob. Agents Chemother. 11 (1999) 1663